Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Kyoji Tsuchikama(Brown Foundation), Zhiqiang An(Xiamen University)
Cited by 746
Related Papers
Exploring the next generation of antibody–drug conjugates
|Nature Reviews Clinical Oncology|2024|505
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
|Proceedings of the National Academy of Sciences|2005|156
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
|Breast Cancer Research|2014|62
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
|Journal for ImmunoTherapy of Cancer|2022|48
HER3 and LINC00052 interplay promotes tumor growth in breast cancer
|Oncotarget|2016|32